• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4
1
1
1

COUNTRY

1

CATEGORIES

  • 8
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
10
10
24

PUBLISHED

0
0
3
24

PRODUCT TYPE

14
10

Search "BioMimetic Therapeutics Inc-Therapeutic Competitors" returned 24 results.

BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2014 Update

Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal injuries and diseases which include orthopedics,...

May 2014
FROM

BioMimetic Therapeutics, Inc. - Strategic SWOT Analysis Review

BioMimetic Therapeutics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...

February 2014
FROM

BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2013 Update

Summary BioMimetic Therapeutics, Inc. (BioMimetic), subsidiary of Wright Medical Group, Inc., is a biotechnology company. It develops and commercializes products for the healing of musculoskeletal...

June 2013
FROM

BioMimetic Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis

BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human platelet-derived...

April 2012
FROM

BioMimetic Therapeutics, Inc. (BMTI) - Financial and Strategic SWOT Analysis Review

BioMimetic Therapeutics, Inc. (BMTI) - Financial and Strategic SWOT Analysis Review Summary BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human...

September 2011
FROM

Rhinovirus Infection - Pipeline Review, H2 2014

Rhinovirus Infection - Pipeline Review, H2 2014 Summary This, ‘Rhinovirus Infection - Pipeline Review, H2 2014’, provides an overview of the Rhinovirus Infection’s therapeutic pipeline. This report...

December 2014
FROM

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

May 2014
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

February 2014
FROM

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Inflammation - Pipeline Review, H1 2014’, provides an overview of the Inflammation’s therapeutic pipeline. This report provides...

June 2014
FROM

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014 Summary This, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014’, provides...

October 2014
FROM

Sickle Cell Disease - Pipeline Review, H1 2014

Sickle Cell Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2014’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This...

April 2014
FROM

Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014

Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014 Summary This, ‘Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014’, provides an overview of the Pseudomonas Aeruginosa Infections’s...

November 2014
FROM

Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Dry Eye Syndrome Therapeutics -...

March 2011
FROM

Regenerative Medicine - Global Strategic Business Report

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World....

June 2014
FROM

Growth Factors (Blood and Tissue) - Global Strategic Business Report

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons,...

June 2014
FROM

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

March 2014
FROM

The World Market for Orthopedic Biomaterials ( Allografts, Ceramics, Polymer Products, BMPs, and HA Viscosupplemental Products)

This report is a complete international focus on the orthopedic biomaterials market. Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture...

May 2011
FROM

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

July 2014
FROM

Serica Technologies, Inc. - Product Pipeline Analysis

Serica Technologies, Inc. - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Serica Technologies, Inc. portfolio of pipeline products....

November 2010
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group